Marlboro maker Altria said on Wednesday it had sent data to the U.S. Food and Drug Administration on growth in illegal nicotine pouches, saying it echoed the early stages of a now massive black market for vapes in the country.
Altria Group Inc (NYSE:MO, ETR:PHM7) shares fell almost 5% after the tobacco alcohol and cannabis conglomerate's second quarter earnings disappointed on waning cigarette demand. The owner of Marlboro-maker Philip Morris posted revenue of $5.2 billion, short of estimates of $5.4 billion.
Altria (MO) came out with quarterly earnings of $1.31 per share, missing the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.31 per share a year ago.
Altria now expects adjusted earnings for the year of $5.07 a share to $5.15 a share.
Altria (NYSE: MO) will report its Q2 2023 results on Wednesday, July 31, and it will likely post an upbeat quarter. We expect the company to post revenue of $5.43 billion and adjusted earnings of $1.35 per share, compared to the consensus estimates of $5.39 billion and $1.34, respectively.
Altria Group's (MO) second-quarter earnings are likely to reflect gains from the company's pricing power and smoke-free product strength amid soft cigarette volumes.
Altria has newfound growth outside of its legacy cigarette business. The company has a rich history of paying and raising its dividend.
Altria is a great income investment with its reliable 8% dividend. It's also a safe haven during market corrections.
Altria's (MO) strategic moves into smoke-free products offer growth potential, though the declining cigarette business raises concerns.
Altria (MO) concluded the recent trading session at $49.80, signifying a +0.77% move from its prior day's close.
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.